ABSTRACT
Objective
The role of reverse shock index multiplied Glasgow coma scale (rSIG) in patients post-trauma with traumatic brain injury (TBI) has not yet been defined well. Our study aimed to investigate the predictive performance of rSIG according to age group.
Method
This is a prospective multi-national and multi-center cohort study using Pan-Asian Trauma Outcome Study registry in Asian-Pacific, conducted on patients post-trauma who visited participating hospitals. The main exposure was low rSIG measured at emergency department. The main outcome was in-hospital mortality. We performed multilevel logistic regression analysis to estimate the association low rSIG and study outcomes. Interaction analysis between rSIG and age group were also conducted.
Results
Low rSIG was significantly associated with an increase in in-hospital mortality in patients post-trauma with and without TBI (aOR (95% CI): 1.49 (1.04–2.13) and 1.71 (1.16–2.53), respectively). The ORs for in-hospital mortality differed according to the age group in patients post-trauma with TBI (1.72 (1.44–1.94) for the young group and 1.13 (1.07–1.52) for the old group; p < 0.05).
Conclusion
Low rSIG is associated with an increase in in-hospital mortality in adult patients post-trauma. However, in patients with TBI, the prediction of mortality is significantly better in younger patient group.
KEYWORDS:
Disclosure statement
No potential conflict of interest was reported by the authors.
Author contributions
Dr. Ryu and Jung had full access to all of the data in the study and take responsibility for the integrity of the data as well as the accuracy of the data analysis.
Study concept and design: Ryu, Heo, and Jung
Acquisition, analysis, or interpretation of data: Ryu and Jung
Drafting of the manuscript: Ryu, Heo, and Jung
Critical revision of the manuscript for important intellectual content: Ryu and Jung
Statistical analysis: Ryu, Heo, and Jung
Obtained funding: Ryu, Heo, and Jung
Administrative, technical or material support: Ryu and Jung
Study supervision: Ryu
Manuscript approval: All authors.